EMBOTRAP II Revascularization Device: payments to doctors
Payments that named EMBOTRAP II Revascularization Device as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $585K
- Providers
- 590
- Transactions
- 1,910
- Average per transaction
- $306
The per-transaction average — $306 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 590 providers the average total is $991, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Medical Device Business Services, Inc. | $514,541 | 88.0% |
| Johnson & Johnson | $67,867 | 11.6% |
| Biosense Webster, Inc. | $2,148 | 0.4% |
| Depuy Synthes Products, Inc. | $161 | 0.0% |